Results were similar for the composite outcome of cardiovascular death or first hospitalization for heart failure. ... Although the complexity is most evident for HFrEF, combination therapies are endorsed and promoted across multiple domains, including
for patients with cardiovascular disease (CVD) who are diagnosed with type 2 diabetes. ... Clinicians should consider sodium-glucose cotransporter-2 (SGLT2) inhibitors or glucagon-like peptide-1 (GLP-1) receptor agonists for patients with diabetes and
explain the higher burden of risk factors for cardiovascular disease. ... American women and white women is thought to be due to cardiovascular disease (CVD), the statement said.
https://acpinternist.org/weekly/archives/2017/06/13/2.htm. Some traditional Chinese medications might be used as a complementary and alternative approach for primary and secondary prevention of cardiovascular disease, ... Thus, some TCM medications might
https://acpinternist.org/weekly/archives/2018/07/03/2.htm. Women with gestational hypertension or preeclampsia during their first pregnancy were more likely to develop risk factors for cardiovascular disease, with ... found. Researchers identified 58,671
More than 10% of patients treated with aspirin therapy for primary cardiovascular disease prevention should probably not have been taking the medication, according to a study. ... Preventative Services Task Force, and other organizations, researchers
and Australia who were ages 70 years and older and had no cardiovascular disease, dementia, or physical disability to receive 100 mg of aspirin (n=9,525) or placebo ... a significantly higher risk of major hemorrhage and did not result in a significantly
All clinicians who care for patients with cardiovascular disease (CVD) have the opportunity to mitigate risks for falling, according to a recent scientific statement from the American Heart Association. ... It is intended to provide consensus on
cardiovascular disease (CVD). ... Earlier menarche or menopause and a history of miscarriage, stillbirth, or hysterectomy were independently associated with a higher risk of cardiovascular disease (CVD) in later life, a study found.
This patient is at high risk for fracture and has a history of cardiovascular disease, making raloxifene a poor choice. ... Although this agent would be suitable for use after denosumab in patients with a high fracture risk, it is contraindicated in